DK118482A - Fremgangsmaade til fremstilling af 2,4,5-trisubstituerede thiazoler eller salte deraf - Google Patents

Fremgangsmaade til fremstilling af 2,4,5-trisubstituerede thiazoler eller salte deraf Download PDF

Info

Publication number
DK118482A
DK118482A DK118482A DK118482A DK118482A DK 118482 A DK118482 A DK 118482A DK 118482 A DK118482 A DK 118482A DK 118482 A DK118482 A DK 118482A DK 118482 A DK118482 A DK 118482A
Authority
DK
Denmark
Prior art keywords
thiazols
trisubstituted
salts
procedure
preparation
Prior art date
Application number
DK118482A
Other languages
Danish (da)
English (en)
Inventor
P G Ferrini
R Goeschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK118482A publication Critical patent/DK118482A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK118482A 1981-03-18 1982-03-17 Fremgangsmaade til fremstilling af 2,4,5-trisubstituerede thiazoler eller salte deraf DK118482A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH183881 1981-03-18

Publications (1)

Publication Number Publication Date
DK118482A true DK118482A (da) 1982-09-19

Family

ID=4219779

Family Applications (1)

Application Number Title Priority Date Filing Date
DK118482A DK118482A (da) 1981-03-18 1982-03-17 Fremgangsmaade til fremstilling af 2,4,5-trisubstituerede thiazoler eller salte deraf

Country Status (16)

Country Link
US (1) US4451471A (fi)
EP (1) EP0061425A3 (fi)
JP (1) JPS57183767A (fi)
KR (1) KR830009066A (fi)
AU (1) AU8166782A (fi)
DK (1) DK118482A (fi)
ES (8) ES510504A0 (fi)
FI (1) FI820877L (fi)
GB (1) GB2098203B (fi)
GR (1) GR78347B (fi)
HU (1) HU187684B (fi)
IL (1) IL65285A (fi)
NO (1) NO820881L (fi)
NZ (1) NZ200038A (fi)
PT (1) PT74593B (fi)
ZA (1) ZA821790B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632930A (en) * 1984-11-30 1986-12-30 E. I. Du Pont De Nemours And Company Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
DE3508666A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische disulfide und ihre anwendung als immunmodulatoren
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
JPS6339868A (ja) * 1986-08-04 1988-02-20 Otsuka Pharmaceut Factory Inc ジ低級アルキルフエノ−ル誘導体
ES2038279T3 (es) * 1987-07-27 1993-07-16 Duphar International Research B.V Metodo para preparar compuestos de tiazol.
AT392788B (de) * 1988-02-03 1991-06-10 Fisons Plc Neue benzimidazolverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE3807232A1 (de) * 1988-03-05 1989-09-14 Bayer Ag Substituierte acrylsaeureester
JP2933739B2 (ja) * 1990-04-09 1999-08-16 明治製菓株式会社 チアゾールまたはイミダゾール誘導体および抗潰瘍剤
US5255697A (en) * 1991-10-23 1993-10-26 Working Inc. Walking support apparatus
JP2636819B2 (ja) 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
CA2381215A1 (en) 1999-08-06 2001-02-15 Takeda Chemical Industries, Ltd. P38map kinase inhibitors
BRPI0706621A2 (pt) * 2006-01-18 2011-04-05 Amgen Inc composto, composição farmacêutica, métodos para tratar um distúrbio mediado por quinase em um mamìfero e para tratar um distúrbio relacionado com a proliferação em um mamìfero, e , uso do composto
WO2009011871A2 (en) * 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of pkb
EP2872509B1 (en) 2012-07-12 2016-09-14 Chiesi Farmaceutici S.p.A. Inhibition of enzymes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate
FR2146161A1 (en) * 1971-07-22 1973-03-02 Roussel Uclaf Thiazolyl thiolacetic acids - analgesics antiinflammatories and antipyretics
US3888870A (en) * 1974-03-08 1975-06-10 Sandoz Ag 2-sulfinyl-thiazoles and oxazoles
US4022607A (en) * 1975-06-09 1977-05-10 Sandoz, Inc. Substituted oxazoles and thiazoles as herbicides

Also Published As

Publication number Publication date
ES8601171A1 (es) 1985-10-16
FI820877L (fi) 1982-09-19
ES8400102A1 (es) 1983-10-16
GB2098203B (en) 1985-05-09
ES537277A0 (es) 1986-01-01
PT74593B (de) 1984-11-27
IL65285A0 (en) 1982-05-31
ES522868A0 (es) 1985-02-01
ES537343A0 (es) 1985-10-16
ES8603498A1 (es) 1985-12-16
EP0061425A2 (de) 1982-09-29
ES537342A0 (es) 1986-01-16
ES8603847A1 (es) 1986-01-01
ES8503677A1 (es) 1985-03-16
EP0061425A3 (de) 1982-12-15
JPS57183767A (en) 1982-11-12
ES537278A0 (es) 1985-12-16
ES522867A0 (es) 1985-12-16
ZA821790B (en) 1983-01-26
ES8502980A1 (es) 1985-02-01
ES8604180A1 (es) 1986-01-16
ES510504A0 (es) 1983-10-16
ES8603499A1 (es) 1985-12-16
NZ200038A (en) 1985-05-31
IL65285A (en) 1985-11-29
ES522869A0 (es) 1985-03-16
GR78347B (fi) 1984-09-26
US4451471A (en) 1984-05-29
HU187684B (en) 1986-02-28
PT74593A (de) 1982-04-01
GB2098203A (en) 1982-11-17
NO820881L (no) 1982-09-20
AU8166782A (en) 1982-09-23
KR830009066A (ko) 1983-12-17

Similar Documents

Publication Publication Date Title
DK127982A (da) Fremgangsmaade til fremstilling af flercycliske forbindelser eller salte,estre eller amider deraf
DK331881A (da) Fremgangsmaade til fremstilling af trisubstituerede imidazolderivater eller salte deraf
DK528982A (da) Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner
DK28282A (da) Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf
DK161147C (da) Analogifremgangsmaade til fremstilling af oe3haa-imidazo-oe5,1-daa-1,2,3,5-tetrazin-4-onderivater
DK160561C (da) Analogifremgangsmaade til fremstilling af 3-aminopregn-5-enderivater eller salte deraf
DK70083D0 (da) Fremgangsmade til fremstilling af pyrroleddikesyreamider eller salte deraf
DK273479A (da) Fremgangsmaade til fremstilling af 5-phenylpyrazol-forbindelser eller salte deraf
DK149856C (da) Fremgangsmaade til fremstilling af 1,3-di- eller 1,3,8-trisubstituerede xanthiner eller fysiologisk acceptable salte deraf
DK118482A (da) Fremgangsmaade til fremstilling af 2,4,5-trisubstituerede thiazoler eller salte deraf
DK493083A (da) Fremgangsmaade til fremstilling af 4-oxo-1,4-dihydronicotinsyrederivater eller salte deraf
DK584384A (da) Kemisk fremgangsmaade til fremstilling af antibiotika l 17392 (deglukoteicoplanin) eller salte deraf
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
DK132883D0 (da) Fremgangsmade til fremstilling af a 41030-kompleks eller enkelte faktorer eller salte deraf samt mikroorganisme til anvendelse herved
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK158227C (da) Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf
DK158457C (da) Analogifremgangsmaade til fremstilling af 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaensyre eller salte heraf
DK115379A (da) Fremgangsmaade til fremstilling af dilignoler eller dilignollignende forbindelser eller salte heraf
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK159971C (da) Analogifremgangsmaade til fremstilling af benzoyl-1-piperazinyl-acylanilider eller salte deraf
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK153539C (da) Fremgangsmaade til fremstilling af 3,3-dimethyl-2-oxosmoersyre eller salte deraf
DK432582A (da) Fremgangsmaade til fremstilling af aminooxazolylforbindelser eller salte deraf
DK476082A (da) Fremgangsmaade til fremstilling af phenolderivater eller salte deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment